London: Families Talk About Treatment Trials
Autosomal-dominant Alzheimer's and Huntington's disease family representatives spoke or showed videos about treatment trials...
6401 RESULTS
Sort By:
Autosomal-dominant Alzheimer's and Huntington's disease family representatives spoke or showed videos about treatment trials...
Eight EMA officials and nine FDA officials took part in a discussion about preclinical trials in autosomal-dominant AD...
Part 2 of Alzforum’s coverage continues with what scientists from inside and outside DIAN said about the prospect of such pre-symptomatic trials...
The charge of this meeting was to begin a dialogue toward the shared goal of offering therapeutic treatment and prevention trials to families with autosomal-dominant AD...
Scientists have long wondered why Parkinson’s disease selectively kills a small group of dopamine-generating neurons...
Watch your language; it could protect you from Alzheimer’s disease...
Move over α-synuclein; your smaller brother wants in on the act...
Researchers report that microglia appear to swallow dendritic spines in the visual cortex of healthy mice when they find themselves in 24-hour-dark conditions...
The few people who have an ApoE2 allele enjoy reduced risk of late-onset Alzheimer’s disease...
Toulouse: Experimental Drug Sensitizes Receptor, Boosts Cognition Clinical Trials on Alzheimer's Disease 2010
Scientists have hoped that knowledge of human genetics would provide new clues as to why some people get diseases that others do not...
It is touted as brain food, but the polyunsaturated fatty acid DHA failed to slow mental decline in AD patients who took it in pill form for one and a half years...
Does Aβ, the quintessential Alzheimer’s disease protein, multiply from a few seeds and spread through brain networks like kudzu taking over a garden patch?...
A compound that partially activates α7 nicotinic acetylcholine receptors has shown promise at surprisingly low doses in early AD clinical trials...
Many scientists said the progress in identifying the basic biology behind FTDs may soon translate into new therapeutic targets...
No filters selected